- Home
- ANNX vs HMST Comparison
ANNX vs HMST Comparison
Compare ANNX & HMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANNX
- HMST
- Stock Information
- Founded
- ANNX 2011
- HMST 1921
- Country
- ANNX United States
- HMST United States
- Employees
- ANNX N/A
- HMST N/A
- Industry
- ANNX Biotechnology: Pharmaceutical Preparations
- HMST Major Banks
- Sector
- ANNX Health Care
- HMST Finance
- Exchange
- ANNX Nasdaq
- HMST Nasdaq
- Market Cap
- ANNX 263.3M
- HMST 246.0M
- IPO Year
- ANNX 2020
- HMST 2012
- Fundamental
- Price
- ANNX $2.56
- HMST $13.24
- Analyst Decision
- ANNX Strong Buy
- HMST Hold
- Analyst Count
- ANNX 4
- HMST 3
- Target Price
- ANNX $12.50
- HMST $14.17
- AVG Volume (30 Days)
- ANNX 1.8M
- HMST 68.7K
- Earning Date
- ANNX 08-11-2025
- HMST 07-28-2025
- Dividend Yield
- ANNX N/A
- HMST N/A
- EPS Growth
- ANNX N/A
- HMST N/A
- EPS
- ANNX N/A
- HMST N/A
- Revenue
- ANNX N/A
- HMST $78,454,000.00
- Revenue This Year
- ANNX N/A
- HMST $161.80
- Revenue Next Year
- ANNX N/A
- HMST $8.90
- P/E Ratio
- ANNX N/A
- HMST N/A
- Revenue Growth
- ANNX N/A
- HMST N/A
- 52 Week Low
- ANNX $1.29
- HMST $8.41
- 52 Week High
- ANNX $7.85
- HMST $16.10
- Technical
- Relative Strength Index (RSI)
- ANNX 54.40
- HMST 64.81
- Support Level
- ANNX $1.85
- HMST $13.14
- Resistance Level
- ANNX $2.97
- HMST $13.67
- Average True Range (ATR)
- ANNX 0.27
- HMST 0.34
- MACD
- ANNX 0.00
- HMST 0.07
- Stochastic Oscillator
- ANNX 60.32
- HMST 83.12
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
About HMST HomeStreet Inc.
HomeStreet Inc is a commercial bank. It provides commercial loans and consumer loans including mortgage loans, deposit products, private banking, and cash management services. The company loan products include commercial business loans and agriculture loans, consumer loans, single family residential mortgages, loans secured by commercial real estate and construction loans for residential and commercial real estate projects.